PURE PLAY (Unprecedented Safety Profile )7 Mar 2025 08:43
THIS IS GOOD ENOUGH FOR ME ! IGNORE THE FUD !
The Company has seen a dramatic increase in therapeutic index in preclinical models, suggesting that AVA6103 could have an unprecedented safety profile in the clinic. AVA6103 has the potential to treat hundreds of thousands of patients with the broad use of the topo I drug class and over 90% of solid tumors expressing FAP
Beijiing Cancer Hospital Write up28 Feb 2025 14:30
Not sure if this has been posted, but ive only just come across it myself, a positive write up from yesterday regarding AVACTA, link is below but you will need to translate it !
Sheppy, no i stopped buying quite a while back thats why i dont post much on here, im just waiting for the price to go up multiples then will re evaluate !
Havent been on here in quite a while and guess who i see straight away, yes its WYN, what a sad human he is, i see he is still trying to bring this stock down for his mates !
Oh ok, so its just a coincidence that when i come on here, which isnt very often, you just happen to already have commented x amount of times ! makes sense now lol !